Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-small Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02447900
What this trial is testing

Marker Guided Breathhold Radiotherapy in NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Steen Riisgaard Mortensen 15
Large-scale testing (Phase 3)UnknownNCT02607592
What this trial is testing

A Prospective Multi-center Phase III Randomized Controlled Trial

Who this might be right for
Carcinoma，Non-Small-Cell Lung
Sun Yat-sen University 293
Testing effectiveness (Phase 2)Study completedNCT00085839
What this trial is testing

Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2

Who this might be right for
Non-Small Cell Lung Cancer
OSI Pharmaceuticals 103
Testing effectiveness (Phase 2)Temporarily pausedNCT02470065
What this trial is testing

Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 38
Testing effectiveness (Phase 2)Study completedNCT04452877
What this trial is testing

Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Novartis Pharmaceuticals 40
Not applicableStudy completedNCT02623257
What this trial is testing

EGFR Mutations on ctDNA in Patients With Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer Metastatic
First People's Hospital of Hangzhou 1,055
Testing effectiveness (Phase 2)Study completedNCT00246181
What this trial is testing

Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Jill Deluca 117
Testing effectiveness (Phase 2)Looking for participantsNCT07104630
What this trial is testing

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Who this might be right for
Non-small Cell Lung Cancer Stage IIINon-small Cell Lung Cancer Stage IVNon-small Cell Lung Cancer+1 more
Case Comprehensive Cancer Center 85
Testing effectiveness (Phase 2)Study completedNCT00271505
What this trial is testing

Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
M.D. Anderson Cancer Center 43
Early research (Phase 1)Study completedNCT01320059
What this trial is testing

Study of 18F-Fluoro-PEG6-IPQA

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)UnknownNCT06697990
What this trial is testing

Cerebrospinal Fluid Immune Microenvironment Mechanism in Anaplastic Lymphoma Kinase Positive Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Tianjin Medical University Cancer Institute and Hospital 12
Not applicableLooking for participantsNCT07487883
What this trial is testing

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

Who this might be right for
Non-Small Cell Lung CancerMalignant NeoplasmPulmonary Nodules+1 more
Peking University People's Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00364780
What this trial is testing

Study of XL647 in Subjects With Non-Small-Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Kadmon Corporation, LLC 55
Not applicableLooking for participantsNCT07452003
What this trial is testing

An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00551369
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 33
Testing effectiveness (Phase 2)Study completedNCT00010218
What this trial is testing

Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 55
Large-scale testing (Phase 3)Looking for participantsNCT07100080
What this trial is testing

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 500
Post-approval studies (Phase 4)Study completedNCT02316327
What this trial is testing

Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Fundacion Clinic per a la Recerca Biomédica 19
Testing effectiveness (Phase 2)UnknownNCT05141786
What this trial is testing

MRG002 in the Treatment of Patients With HER2-mutated Unresectable/Metastatic Non-small Cell Lung Cancer (NSCLC).

Who this might be right for
Non-small- Cell Lung Cancer (NSCLC)
Shanghai Miracogen Inc. 100
Not applicableStudy completedNCT05770869
What this trial is testing

MHealth ALIBIRD: A Digital Health Care Model

Who this might be right for
Thoracic Neoplasms
Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares 20
Next Page